loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering Ruxolitinib

    Client Email Product
    Menu

    Ruxolitinib

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 INCYTE CORP (179)

    filter

    01 10016429*PED (5)

    02 10610530*PED (1)

    03 10639310*PED (1)

    04 10758543*PED (1)

    05 10869870*PED (1)

    06 11219624*PED (1)

    07 7598257 (11)

    08 7598257*PED (6)

    09 8415362 (6)

    10 10016429 (10)

    11 10610530 (2)

    12 10639310 (1)

    13 10758543 (1)

    14 10869870 (2)

    15 11219624 (1)

    16 11510923 (1)

    17 11571425 (1)

    18 11590136 (2)

    19 11590137 (1)

    20 11590138 (1)

    21 11602536 (1)

    22 8415362*PED (6)

    23 8722693 (6)

    24 8722693*PED (6)

    25 8822481 (27)

    26 8822481*PED (6)

    27 8829013 (20)

    28 8829013*PED (5)

    29 9079912 (22)

    30 9079912*PED (6)

    31 9814722 (10)

    32 9814722*PED (5)

    33 9974790 (2)

    34 9974790*PED (1)

    filter

    01 Y (23)

    02 Blank (156)

    filter

    01 Y (26)

    02 Blank (153)

    filter

    01 2026-12-12 (35)

    02 2027-06-12 (13)

    03 2027-12-24 (17)

    04 2028-06-12 (65)

    05 2028-06-24 (12)

    06 2028-12-12 (23)

    07 2031-05-20 (7)

    08 2031-11-20 (3)

    09 2040-06-10 (1)

    10 2040-09-04 (2)

    11 2041-05-05 (1)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    8822481
    2028-06-12
    U-1573
    202192
    USE OF RUXOLITINIB (JAKAFI) FOR INHIBITING JANUS ASSOCIATED KINASES (JAKS) JAK1 AND/OR JAK2.
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    8822481
    2028-06-12
    U-1573
    202192
    USE OF RUXOLITINIB (JAKAFI) FOR INHIBITING JANUS ASSOCIATED KINASES (JAKS) JAK1 AND/OR JAK2.
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    8822481
    2028-06-12
    U-1573
    202192
    USE OF RUXOLITINIB (JAKAFI) FOR INHIBITING JANUS ASSOCIATED KINASES (JAKS) JAK1 AND/OR JAK2.
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    8822481
    2028-06-12
    U-1573
    202192
    USE OF RUXOLITINIB (JAKAFI) FOR INHIBITING JANUS ASSOCIATED KINASES (JAKS) JAK1 AND/OR JAK2.
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    8822481
    2028-06-12
    U-1573
    202192
    USE OF RUXOLITINIB (JAKAFI) FOR INHIBITING JANUS ASSOCIATED KINASES (JAKS) JAK1 AND/OR JAK2.
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    8822481
    2028-06-12
    U-3404
    215309
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    9079912
    2026-12-12
    U-3404
    215309
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    10610530
    2028-06-12
    U-3404
    215309
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    10869870
    2031-05-20
    U-3404
    215309
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    INCYTE CORP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RUXOLITINIB PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    9974790
    2026-12-12
    U-3404
    215309
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY